EUVIMEDEUVIMED entdecken
Crossref

Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice

Sarita Rani, Rakesh K Sahoo, Ashutosh Mahale, Kanan Panchal, Akash Chaurasiya, Onkar Kulkarni iD, Kaushik Kuche, Sanyog Jain iD, Kartik T Nakhate, Ajazuddin, Umesh Gupta iD

Bioconjugate Chemistry · 2023

DOI: 10.1021/acs.bioconjchem.3c00210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von Sarita Rani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajm…. Hauptthemen laut MEDLINE: Selenium, Prodrugs, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most cancer patients rarely benefit from monodrug therapy because of both cancer complexity and tumor environment. One of the main reasons for this failure is insufficient accumulation of the optimal dose at the tumorous site. Our investigation implies a promising strategy to engineer prodrug nanoparticles (NPs) of bortezomib (BTZ) and selenium (Se) using sialic acid (SAL) as a ligand to improve breast cancer therapy. BTZ was conjugated with SAL and HPMA (N-2-hydroxypropyl methacrylamide) to prepare a prodrug conjugate; BTZ-SAL-HPMA (BSAL-HP) and then fabricated into prodrug NPs with Se (Se_BSAL-HP prodrug NPs). The self-assembly of prodrug NPs functionalized with Se showed size (204.13 ± 0.02 nm) and zeta potential (-31.0 ± 0.11 mV) in dynamic light scattering (DLS) experiments and spherical shape in TEM and SEM analysis. Good stability and low pH drug release profile were characterized by Se_BSAL-HP prodrug NPs. The tumor-selective boronate-ester-based prodrug NPs of BTZ in combination with Se endowed a synergistic effect against cancer cells. Compared to prodrug conjugate, Se_BSAL-HP prodrug NPs exhibited higher cell cytotoxicity and enhanced cellular internalization with significant changes in mitochondria membrane potential (MMP). Elevated apoptosis was observed in the (G2/M) phase of the cell cycle for Se_BSAL-HP prodrug NPs (2.7-fold) higher than BTZ. In vivo studies were performed on Sprague-Dawley rats and resulted in positive trends. The increased therapeutic activity of Se_BSAL-HP prodrug NPs inhibited primary tumor growth and showed 43.05 fold decrease in tumor volume than the control in 4T1 tumor bearing mice. The surprising and remarkable outcomes for Se_BSAL-HP prodrug NPs were probably due to the ROS triggering effect of boronate ester and selenium given together.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeleniumProdrugsNeoplasmsRatsAnimalsMiceRats, Sprague-DawleyN-Acetylneuraminic AcidBortezomibEstersMethacrylates

Substanzen

SeleniumProdrugsN-Acetylneuraminic AcidBortezomibEstershydroxypropyl methacrylateMethacrylates

Autor:innen und Institutionen

  • Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan 305817, India.
  • Department of Pharmacy, Birla Institute of Technology & Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal Medchal District, Telangana 500078, India.
  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar Campus, Sector-67, Punjab 160062, India.
  • Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra 424001, India.
  • Rungta College of Pharmaceutical Sciences and Research, Kohka-Kurud Road, Bhilai, Chhattisgarh 490024, India.

ORCID-Profile: Onkar Kulkarni, Sanyog Jain, Umesh Gupta

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Rani, S., Sahoo, R. K., Mahale, A., Panchal, K., Chaurasiya, A., Kulkarni, O., Kuche, K., Jain, S., Nakhate, K. T., Ajazuddin, & Gupta, U. (2023). Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00210

Vancouver

Rani S, Sahoo RK, Mahale A, Panchal K, Chaurasiya A, Kulkarni O, et al. Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00210

BibTeX
@article{Rani2023,
  author = {Rani, Sarita and Sahoo, Rakesh K and Mahale, Ashutosh and Panchal, Kanan and Chaurasiya, Akash and Kulkarni, Onkar and Kuche, Kaushik and Jain, Sanyog and Nakhate, Kartik T and Ajazuddin and Gupta, Umesh},
  title = {Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice},
  journal = {Bioconjugate Chemistry},
  year = {2023},
  doi = {10.1021/acs.bioconjchem.3c00210}
}
Kostenlos starten →